Global Oral COVID-19 Drug Market Growth 2023-2029

January 2023 | 78 pages | ID: G5D24F625BC9EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Oral COVID-19 Drug Industry Forecast” looks at past sales and reviews total world Oral COVID-19 Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral COVID-19 Drug sales for 2023 through 2029. With Oral COVID-19 Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral COVID-19 Drug industry.

This Insight Report provides a comprehensive analysis of the global Oral COVID-19 Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral COVID-19 Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral COVID-19 Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral COVID-19 Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral COVID-19 Drug.

The global Oral COVID-19 Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Oral COVID-19 Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Oral COVID-19 Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Oral COVID-19 Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Oral COVID-19 Drug players cover Pfizer, MSD and Ridgeback and Shionogi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral COVID-19 Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Tablet
• Capsule

Segmentation by application

• Hospital
• Clinics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• MSD and Ridgeback
• Shionogi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral COVID-19 Drug market?

What factors are driving Oral COVID-19 Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral COVID-19 Drug market opportunities vary by end market size?

How does Oral COVID-19 Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral COVID-19 Drug Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Oral COVID-19 Drug by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Oral COVID-19 Drug by Country/Region, 2018, 2022 & 2029
2.2 Oral COVID-19 Drug Segment by Type
  2.2.1 Tablet
  2.2.2 Capsule
2.3 Oral COVID-19 Drug Sales by Type
  2.3.1 Global Oral COVID-19 Drug Sales Market Share by Type (2018-2023)
  2.3.2 Global Oral COVID-19 Drug Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Oral COVID-19 Drug Sale Price by Type (2018-2023)
2.4 Oral COVID-19 Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Clinics
2.5 Oral COVID-19 Drug Sales by Application
  2.5.1 Global Oral COVID-19 Drug Sale Market Share by Application (2018-2023)
  2.5.2 Global Oral COVID-19 Drug Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Oral COVID-19 Drug Sale Price by Application (2018-2023)

3 GLOBAL ORAL COVID-19 DRUG BY COMPANY

3.1 Global Oral COVID-19 Drug Breakdown Data by Company
  3.1.1 Global Oral COVID-19 Drug Annual Sales by Company (2018-2023)
  3.1.2 Global Oral COVID-19 Drug Sales Market Share by Company (2018-2023)
3.2 Global Oral COVID-19 Drug Annual Revenue by Company (2018-2023)
  3.2.1 Global Oral COVID-19 Drug Revenue by Company (2018-2023)
  3.2.2 Global Oral COVID-19 Drug Revenue Market Share by Company (2018-2023)
3.3 Global Oral COVID-19 Drug Sale Price by Company
3.4 Key Manufacturers Oral COVID-19 Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oral COVID-19 Drug Product Location Distribution
  3.4.2 Players Oral COVID-19 Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ORAL COVID-19 DRUG BY GEOGRAPHIC REGION

4.1 World Historic Oral COVID-19 Drug Market Size by Geographic Region (2018-2023)
  4.1.1 Global Oral COVID-19 Drug Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Oral COVID-19 Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oral COVID-19 Drug Market Size by Country/Region (2018-2023)
  4.2.1 Global Oral COVID-19 Drug Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Oral COVID-19 Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oral COVID-19 Drug Sales Growth
4.4 APAC Oral COVID-19 Drug Sales Growth
4.5 Europe Oral COVID-19 Drug Sales Growth
4.6 Middle East & Africa Oral COVID-19 Drug Sales Growth

5 AMERICAS

5.1 Americas Oral COVID-19 Drug Sales by Country
  5.1.1 Americas Oral COVID-19 Drug Sales by Country (2018-2023)
  5.1.2 Americas Oral COVID-19 Drug Revenue by Country (2018-2023)
5.2 Americas Oral COVID-19 Drug Sales by Type
5.3 Americas Oral COVID-19 Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral COVID-19 Drug Sales by Region
  6.1.1 APAC Oral COVID-19 Drug Sales by Region (2018-2023)
  6.1.2 APAC Oral COVID-19 Drug Revenue by Region (2018-2023)
6.2 APAC Oral COVID-19 Drug Sales by Type
6.3 APAC Oral COVID-19 Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oral COVID-19 Drug by Country
  7.1.1 Europe Oral COVID-19 Drug Sales by Country (2018-2023)
  7.1.2 Europe Oral COVID-19 Drug Revenue by Country (2018-2023)
7.2 Europe Oral COVID-19 Drug Sales by Type
7.3 Europe Oral COVID-19 Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral COVID-19 Drug by Country
  8.1.1 Middle East & Africa Oral COVID-19 Drug Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Oral COVID-19 Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Oral COVID-19 Drug Sales by Type
8.3 Middle East & Africa Oral COVID-19 Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral COVID-19 Drug
10.3 Manufacturing Process Analysis of Oral COVID-19 Drug
10.4 Industry Chain Structure of Oral COVID-19 Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oral COVID-19 Drug Distributors
11.3 Oral COVID-19 Drug Customer

12 WORLD FORECAST REVIEW FOR ORAL COVID-19 DRUG BY GEOGRAPHIC REGION

12.1 Global Oral COVID-19 Drug Market Size Forecast by Region
  12.1.1 Global Oral COVID-19 Drug Forecast by Region (2024-2029)
  12.1.2 Global Oral COVID-19 Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral COVID-19 Drug Forecast by Type
12.7 Global Oral COVID-19 Drug Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Oral COVID-19 Drug Product Portfolios and Specifications
  13.1.3 Pfizer Oral COVID-19 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 MSD and Ridgeback
  13.2.1 MSD and Ridgeback Company Information
  13.2.2 MSD and Ridgeback Oral COVID-19 Drug Product Portfolios and Specifications
  13.2.3 MSD and Ridgeback Oral COVID-19 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 MSD and Ridgeback Main Business Overview
  13.2.5 MSD and Ridgeback Latest Developments
13.3 Shionogi
  13.3.1 Shionogi Company Information
  13.3.2 Shionogi Oral COVID-19 Drug Product Portfolios and Specifications
  13.3.3 Shionogi Oral COVID-19 Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Shionogi Main Business Overview
  13.3.5 Shionogi Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral COVID-19 Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oral COVID-19 Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Capsule
Table 5. Global Oral COVID-19 Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Oral COVID-19 Drug Sales Market Share by Type (2018-2023)
Table 7. Global Oral COVID-19 Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oral COVID-19 Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Oral COVID-19 Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Oral COVID-19 Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Oral COVID-19 Drug Sales Market Share by Application (2018-2023)
Table 12. Global Oral COVID-19 Drug Revenue by Application (2018-2023)
Table 13. Global Oral COVID-19 Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Oral COVID-19 Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Oral COVID-19 Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Oral COVID-19 Drug Sales Market Share by Company (2018-2023)
Table 17. Global Oral COVID-19 Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oral COVID-19 Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Oral COVID-19 Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Oral COVID-19 Drug Producing Area Distribution and Sales Area
Table 21. Players Oral COVID-19 Drug Products Offered
Table 22. Oral COVID-19 Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oral COVID-19 Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Oral COVID-19 Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oral COVID-19 Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oral COVID-19 Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oral COVID-19 Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Oral COVID-19 Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oral COVID-19 Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oral COVID-19 Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oral COVID-19 Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Oral COVID-19 Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Oral COVID-19 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oral COVID-19 Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Oral COVID-19 Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Oral COVID-19 Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Oral COVID-19 Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Oral COVID-19 Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Oral COVID-19 Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oral COVID-19 Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Oral COVID-19 Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Oral COVID-19 Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Oral COVID-19 Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Oral COVID-19 Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Oral COVID-19 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oral COVID-19 Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Oral COVID-19 Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Oral COVID-19 Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Oral COVID-19 Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Oral COVID-19 Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oral COVID-19 Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oral COVID-19 Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oral COVID-19 Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Oral COVID-19 Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Oral COVID-19 Drug
Table 58. Key Market Challenges & Risks of Oral COVID-19 Drug
Table 59. Key Industry Trends of Oral COVID-19 Drug
Table 60. Oral COVID-19 Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oral COVID-19 Drug Distributors List
Table 63. Oral COVID-19 Drug Customer List
Table 64. Global Oral COVID-19 Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Oral COVID-19 Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oral COVID-19 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Oral COVID-19 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oral COVID-19 Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Oral COVID-19 Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oral COVID-19 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Oral COVID-19 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oral COVID-19 Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Oral COVID-19 Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oral COVID-19 Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Oral COVID-19 Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oral COVID-19 Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Oral COVID-19 Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Oral COVID-19 Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Oral COVID-19 Drug Product Portfolios and Specifications
Table 80. Pfizer Oral COVID-19 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. MSD and Ridgeback Basic Information, Oral COVID-19 Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. MSD and Ridgeback Oral COVID-19 Drug Product Portfolios and Specifications
Table 85. MSD and Ridgeback Oral COVID-19 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. MSD and Ridgeback Main Business
Table 87. MSD and Ridgeback Latest Developments
Table 88. Shionogi Basic Information, Oral COVID-19 Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Shionogi Oral COVID-19 Drug Product Portfolios and Specifications
Table 90. Shionogi Oral COVID-19 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Shionogi Main Business
Table 92. Shionogi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Oral COVID-19 Drug
Figure 2. Oral COVID-19 Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral COVID-19 Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oral COVID-19 Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oral COVID-19 Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Capsule
Figure 11. Global Oral COVID-19 Drug Sales Market Share by Type in 2022
Figure 12. Global Oral COVID-19 Drug Revenue Market Share by Type (2018-2023)
Figure 13. Oral COVID-19 Drug Consumed in Hospital
Figure 14. Global Oral COVID-19 Drug Market: Hospital (2018-2023) & (K Units)
Figure 15. Oral COVID-19 Drug Consumed in Clinics
Figure 16. Global Oral COVID-19 Drug Market: Clinics (2018-2023) & (K Units)
Figure 17. Global Oral COVID-19 Drug Sales Market Share by Application (2022)
Figure 18. Global Oral COVID-19 Drug Revenue Market Share by Application in 2022
Figure 19. Oral COVID-19 Drug Sales Market by Company in 2022 (K Units)
Figure 20. Global Oral COVID-19 Drug Sales Market Share by Company in 2022
Figure 21. Oral COVID-19 Drug Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Oral COVID-19 Drug Revenue Market Share by Company in 2022
Figure 23. Global Oral COVID-19 Drug Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Oral COVID-19 Drug Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Oral COVID-19 Drug Sales 2018-2023 (K Units)
Figure 26. Americas Oral COVID-19 Drug Revenue 2018-2023 ($ Millions)
Figure 27. APAC Oral COVID-19 Drug Sales 2018-2023 (K Units)
Figure 28. APAC Oral COVID-19 Drug Revenue 2018-2023 ($ Millions)
Figure 29. Europe Oral COVID-19 Drug Sales 2018-2023 (K Units)
Figure 30. Europe Oral COVID-19 Drug Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Oral COVID-19 Drug Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Oral COVID-19 Drug Revenue 2018-2023 ($ Millions)
Figure 33. Americas Oral COVID-19 Drug Sales Market Share by Country in 2022
Figure 34. Americas Oral COVID-19 Drug Revenue Market Share by Country in 2022
Figure 35. Americas Oral COVID-19 Drug Sales Market Share by Type (2018-2023)
Figure 36. Americas Oral COVID-19 Drug Sales Market Share by Application (2018-2023)
Figure 37. United States Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Oral COVID-19 Drug Sales Market Share by Region in 2022
Figure 42. APAC Oral COVID-19 Drug Revenue Market Share by Regions in 2022
Figure 43. APAC Oral COVID-19 Drug Sales Market Share by Type (2018-2023)
Figure 44. APAC Oral COVID-19 Drug Sales Market Share by Application (2018-2023)
Figure 45. China Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Oral COVID-19 Drug Sales Market Share by Country in 2022
Figure 53. Europe Oral COVID-19 Drug Revenue Market Share by Country in 2022
Figure 54. Europe Oral COVID-19 Drug Sales Market Share by Type (2018-2023)
Figure 55. Europe Oral COVID-19 Drug Sales Market Share by Application (2018-2023)
Figure 56. Germany Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Oral COVID-19 Drug Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Oral COVID-19 Drug Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Oral COVID-19 Drug Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Oral COVID-19 Drug Sales Market Share by Application (2018-2023)
Figure 65. Egypt Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Oral COVID-19 Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Oral COVID-19 Drug in 2022
Figure 71. Manufacturing Process Analysis of Oral COVID-19 Drug
Figure 72. Industry Chain Structure of Oral COVID-19 Drug
Figure 73. Channels of Distribution
Figure 74. Global Oral COVID-19 Drug Sales Market Forecast by Region (2024-2029)
Figure 75. Global Oral COVID-19 Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Oral COVID-19 Drug Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Oral COVID-19 Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Oral COVID-19 Drug Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Oral COVID-19 Drug Revenue Market Share Forecast by Application (2024-2029)